Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 9Warts 2Uterine Cervical Neoplasms 2Condylomata Acuminata 2Acquired Immunodeficiency Syndrome 2Uterine Cervical Dysplasia 1Neoplasms 1High Grade Anal Canal Intraepithelial Neoplasia 1Hematologic Neoplasms 1HIV Infections 1Cancer Survivor 1

Interventions

Trichloroacetic Acid 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3human papillomavirus vaccine, L1 type 16, 18 2Vaccines 2Papillomavirus Vaccines 2Human Papillomavirus Recombinant Vaccine nonavalent 2Ethanol 2nanocurcumin 1hecolin 1Zinc 1Vaccination 1Tuberculin 1Surgical Procedures, Operative 1Podophyllin 1PRA1 protein, Candida albicans 1Medical Records 1Measles-Mumps-Rubella Vaccine 1Lasers, Gas 1Imiquimod 1Hepatitis B Vaccines 1Electrocoagulation 1Diathermy 1Cyclophosphamide 1Curcumin 1Cryotherapy 1Cantharidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Condylomata Acuminata × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT05087849 2025-10-02

Intralesional HPV Vaccine for Condylomata

University of California, San Francisco

Phase 1/2 Completed
2 enrolled 7 charts

Condylomata Acuminata, Warts

NCT06681636 2024-11-08

HPV9vxFSW

National Institute of Hygiene and Epidemiology, Vietnam

Phase 2 Not yet recruiting
300 enrolled
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡